Intestinal Research

Inflammatory Bowel Diseases
Efficacy and tolerability of exclusive enteral nutrition in adult patients with complicated Crohn’s disease: Sanchit Sharma, Arti Gupta, Saurabh Kedia, Samagra Agarwal, Namrata Singh, Sandeep Goyal, Saransh Jain, Vipin Gupta, Pabitra Sahu, Sudheer Kumar Vuyyuru, Bhaskar Kante, Raju Sharma, Rajesh Panwar, Peush Sahni, Govind Makharia, Vineet Ahuja; Intest Res. 2021;19(3):291-300. Published online May 26, 2020; DOI: https://doi.org/10.5217/ir.2019.09172
Web of Science 11 Crossref 11; Full text PubReader ePub PDF Supplementary Material

Trends of inflammatory bowel disease at a tertiary care center in northern India: Ajit Sood, Kirandeep Kaur, Arshdeep Singh, Vandana Midha, Ramit Mahajan, Namita Bansal, Varun Mehta, Dharmatma Singh; Intest Res. 2021;19(3):282-290. Published online August 18, 2020; DOI: https://doi.org/10.5217/ir.2020.00010
Web of Science 12 Crossref 10; Full text PubReader ePub PDF Supplementary Material

IBD
Effect of resistance exercise training on Crohn’s disease patients: Konstantinos Papadimitriou; Intest Res. 2021;19(3):275-281. Published online November 20, 2020; DOI: https://doi.org/10.5217/ir.2020.00043
Web of Science 9 Crossref 10; Full text PubReader ePub PDF

Management of Clostridioides difficile infection in patients with inflammatory bowel disease: Sahil Khanna; Intest Res. 2021;19(3):265-274. Published online August 18, 2020; DOI: https://doi.org/10.5217/ir.2020.00045
Web of Science 21 Crossref 25; Full text PubReader ePub PDF

Correlation of serum levels of anti-tumor necrosis factor agents with perianal fistula healing in Crohn’s disease: a narrative review: Eron Fabio Miranda, Rodrigo Bremer Nones, Paulo Gustavo Kotze; Intest Res. 2021;19(3):255-264. Published online November 6, 2020; DOI: https://doi.org/10.5217/ir.2020.00029
Web of Science 6 Crossref 6; Full text PubReader ePub PDF

Non-cirrhotic portal hypertension related to azathioprine therapy in a patient with Crohn’s disease: Jong Won Seo, Eun Soo Kim, Man-Hoon Han, Young Oh Kweon; Intest Res. 2021;19(2):247-251. Published online July 2, 2020; DOI: https://doi.org/10.5217/ir.2020.00016
Web of Science 3 Crossref 5; Full text PubReader ePub PDF

Inflammatory Bowel Diseases
Prospective validation of CD4⁺CD25⁺FOXP3⁺ T-regulatory cells as an immunological marker to differentiate intestinal tuberculosis from Crohn’s disease: Ritika Rampal, Saurabh Kedia, Mohamad Nahidul Wari, Deepak Madhu, Amit Kumar Singh, Veena Tiwari, V. Pratap Mouli, Srikant Mohta, Govind Makharia, Vineet Ahuja; Intest Res. 2021;19(2):232-238. Published online May 8, 2020; DOI: https://doi.org/10.5217/ir.2019.09181
Web of Science 7 Crossref 9; Full text PubReader ePub PDF

Effect of acid-reducing agents on clinical relapse in ulcerative colitis with pH-dependent-released 5-aminosalicylic acid: a multicenter retrospective study in Japan: Yosuke Shimodaira, Kengo Onochi, Kenta Watanabe, So Takahashi, Sho Fukuda, Noboru Watanabe, Shigeto Koizumi, Tamotsu Matsuhashi, Katsunori Iijima; Intest Res. 2021;19(2):225-231. Published online August 18, 2020; DOI: https://doi.org/10.5217/ir.2020.00023
Web of Science 3 Crossref 2; Full text PubReader ePub PDF

Ustekinumab for the treatment of refractory pediatric Crohn’s disease: a single-center experience: Alexandra Cohen, Najma Ahmed, Ana Sant’Anna; Intest Res. 2021;19(2):217-224. Published online April 22, 2020; DOI: https://doi.org/10.5217/ir.2019.09164
Web of Science 6 Crossref 9; Full text PubReader ePub PDF

Colitis and Crohn’s Foundation (India): a first nationwide inflammatory bowel disease registry: Ajit Sood, Kirandeep Kaur, Ramit Mahajan, Vandana Midha, Arshdeep Singh, Sarit Sharma, Amarender Singh Puri, Bhabhadev Goswami, Devendra Desai, C. Ganesh Pai, Kiran Peddi, Mathew Philip, Rakesh Kochhar, Sandeep Nijhawan, Shobna Bhatia, N. Sridhara Rao; Intest Res. 2021;19(2):206-216. Published online July 13, 2020; DOI: https://doi.org/10.5217/ir.2019.09169
Web of Science 19 Crossref 20; Full text PubReader ePub PDF

Yarrow oil ameliorates ulcerative colitis in mice model via regulating the NF-κB and PPAR-γ pathways: Maged E. Mohamed, Sahar A. Elsayed, Hafez R. Madkor, Heba M. Saad Eldien, Omar M. Mohafez; Intest Res. 2021;19(2):194-205. Published online August 21, 2020; DOI: https://doi.org/10.5217/ir.2020.00021
Web of Science 16 Crossref 15; Full text PubReader ePub PDF

Temporal trend in the natural history of ulcerative colitis in a country with a low incidence of ulcerative colitis from 2000 through 2018: Satimai Aniwan, Julajak Limsrivilai, Supot Pongprasobchai, Nonthalee Pausawasdi, Piyapan Prueksapanich, Natanong Kongtub, Rungsun Rerknimitr; Intest Res. 2021;19(2):186-193. Published online August 18, 2020; DOI: https://doi.org/10.5217/ir.2020.00028
Web of Science 12 Crossref 12; Full text PubReader ePub PDF

IBD
Anti-inflammatory diet and inflammatory bowel disease: what clinicians and patients should know?: Nor Hamizah Shafiee, Zahara Abdul Manaf, Norfilza M. Mokhtar, Raja Affendi Raja Ali; Intest Res. 2021;19(2):171-185. Published online February 3, 2021; DOI: https://doi.org/10.5217/ir.2020.00035
Web of Science 19 Crossref 18; Full text PubReader ePub PDF

The impact of tobacco smoking on treatment choice and efficacy in inflammatory bowel disease: Steven Nicolaides, Abhinav Vasudevan, Tony Long, Daniel van Langenberg; Intest Res. 2021;19(2):158-170. Published online October 13, 2020; DOI: https://doi.org/10.5217/ir.2020.00008
Web of Science 7 Crossref 7; Full text PubReader ePub PDF

Rapid prediction of 1-year efficacy of tofacitinib for treating refractory ulcerative colitis: Hiromichi Shimizu, Toshimitsu Fujii, Shuji Hibiya, Maiko Motobayashi, Kohei Suzuki, Kento Takenaka, Eiko Saito, Masakazu Nagahori, Kazuo Ohtsuka, Mamoru Watanabe; Intest Res. 2021;19(1):115-118. Published online June 11, 2020; DOI: https://doi.org/10.5217/ir.2020.00030
Web of Science 12 Crossref 12; Full text PubReader ePub PDF Supplementary Material

IBD